News Real world data will help AZ's Farxiga in cardio battle AZ hopes data will boost sales of its Farxiga.
News Pharma attacks plan to ration new drugs in England Plans to ration and delay use of novel drugs in England have been condemned by the pharma industry and a health charity.
Views & Analysis The Berlin Declaration – driving early action in type 2 diab... International initiative helps countries focus on best policies for overcoming diabetes.
News Novo Nordisk looking at M&A to revive fortunes, says CEO Novo Nordisk’s new CEO Lars Fruergaard Joergensen says it is considering M&A to shore up performance as its key US diabetes sales come under pressure.
Views & Analysis Disruptive innovation, integrated care the only way forward,... Peter Guenter, head of Sanofi’s Diabetes & Cardiovascular business, on the future of chronic disease care.
News Pfizer and Merck's diabetes contender looks to challenge Jar... Merck and Pfizer have Boehringer and Lilly in their sights with ertugliflozin
News Isomorphic adds MSD to partner roster, and other deals It's been a busy dealmaking week, with Isomorphic Labs, fresh from a $5 billion financing, adding MSD to its list of research alliances.
Sales & Marketing Sponsored Securing your ROI: Turning post-acquisition integration into... Join Forinnovia and Little Cube Consulting for a webinar on securing post-acquisition ROI.